North America Extracorporeal Membrane Oxygenation Machine Market By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), And Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts (2016 To 2021)

North America Extracorporeal Membrane Oxygenation Machine Market By Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), And Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts (2016 To 2021)

ID: 4978 | Pages: 145 | November 2017 | Region: North America


North America Extracorporeal Membrane Oxygenation Machine Market Size is expected to grow at a 4.12% CAGR from 2016 to 2021 and it is projected that the North-America market was valued at USD 86.52 million in 2016 and is anticipated to reach USD 105.87 million by 2021.

ECMO stands for extracorporeal membrane oxygenation. The ECMO machine is similar to the heart-lung by-pass machine used in open-heart surgery. It pumps and oxygenates a patient's blood outside the body, allowing the heart and lungs to rest. When you are connected to an ECMO, blood flows through tubing to an artificial lung in the machine that adds oxygen and takes out carbon dioxide; then the blood is warmed to body temperature and pumped back into your body. There are two types of ECMO. The VA ECMO is connected to both a vein and an artery and is used when there are problems with both the heart and lungs. The VV ECMO is connected to one or more veins, usually near the heart, and is used when the problem is only in the lungs. USCF is also now using a smaller portable ECMO device that is light enough to be carried by one person and can be transported in an ambulance or helicopter, making it possible to provide ECMO relief in emergency cases.

The growth of the market can be credited to the rise in the number of cases of cardiovascular and respiratory diseases, the increase in the adoption of ECMO as a bridge to lung transplantation, increasing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements. In addition, the increase in the geriatric population and the number of people suffering from diseases in populous countries are factors that are projected to drive the growth of the market. Moreover, surge in the adoption of unhealthy lifestyle and the subsequent development of lifestyle ailments are projected to further expand the COPD incidence rate. Identified risk factors, such as the increase in the tobacco consumption trend in both, males and females, are further supporting the growth of the market. Be that as it may, complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures along with high cost and lack of skilled professionals is a challenge to the market.

The North America Extracorporeal Membrane Oxygenation Machine Market Segmentation on the basis of Modality and Application. On the basis of Modality, it is segmented into Veno-Arterial (VA), Veno-Venous (VV) and Arterio-Venous (AV). The veno-venous (VV) segment is expected to account for the largest share of this market segment. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the coming years. On the basis of application, it is segmented into Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment accounts for the largest share of this market segment.

On the basis of geography, the market is analyzed under various regions namely U.S. and Canada. North America held the largest share of the market.  The favorable reimbursement scenario, rising incidence of lung cancer, and the presence of a large number of ECMO centers in the U.S. is expected to boost the market for ECMO systems in North America.

Some of the Major North America Extracorporeal Membrane Oxygenation Machine Market Leaders are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc. and EUROSETS S.r.l.

1.Introduction                                                                                  

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 Epidemology                                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Modality                                                                      

                                5.1.1 Introduction                                                           

                                5.1.2 Venovenous ECMO                                                             

                                5.1.3 Venoarterial ECMO                                                             

                                5.1.4 Arteriovenous ECMO                                                         

                                5.1.5  Y-o-Y Growth Analysis, By Modality                                                            

                                5.1.6  Market Attractiveness Analysis, By Modality                                                          

                                5.1.7  Market Share Analysis, By Modality                                                            

                5.2 Application                                                                 

                                5.2.1 Introduction                                                           

                                5.2.2 Respiratory Applications                                                   

                                                5.2.2.1 Neonates                                             

                                                5.2.2.2 Pediatrics                                             

                                                5.2.2.3 Adults                                    

                                5.2.3 Cardiac Applications                                                            

                                                5.2.3.1 Neonates                                             

                                                5.2.3.2 Pediatrics                                             

                                                5.2.3.3 Adults                                    

                                5.2.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)                                                        

                                                5.2.4.1 Neonates                                             

                                                5.2.4.2 Pediatrics                                             

                                                5.2.4.3 Adults                                    

                                5.2.5 Y-o-Y Growth Analysis, By Application                                                         

                                5.2.6 Market Attractiveness Analysis, By Application                                                       

                                5.2.7 Market Share Analysis, By Application                                                        

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Modality                                         

                                                6.1.3.3 By Application                                    

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Application                                    

                                                6.1.4.3 By Type                                 

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Modality                                         

                                                6.1.5.3 By Application                                    

                6.2 United States                                                                            

                6.3 Canada                                                                         

7.Strategic Analysis                                                                                        

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8.Market Leaders' Analysis                                                                                         

                8.1 Getinge Group                                                                          

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Medtronic plc                                                                            

                8.3 LivaNova PLC                                                                             

                8.4 XENIOS AG                                                                 

                8.5 Terumo Corporation                                                                               

                8.6 MicroPort Scientific Corporation                                                                       

                8.7 NIPRO Corporation                                                                 

                8.8 OriGen Biomedical Inc.                                                                          

                8.9 ALung Technologies Inc.                                                                       

                8.10 EUROSETS S.r.l.                                                                       

9.Competitive Landscape                                                                                            

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10.Market Outlook and Investment Opportunities                                                                                          

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Modality and Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North America Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  2. North America Veno-Arterial (VA) Market By Region, From 2016-2021 ( USD Million )
  3. North America Veno-Venous (VV) Market By Region, From 2016-2021 ( USD Million )
  4. North America Arterio-Venous (AV) Market By Region, From 2016-2021 ( USD Million )
  5. North America Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  6. North America Respiratory Market By Region, From 2016-2021 ( USD Million )
  7. North America Cardiac Market By Region, From 2016-2021 ( USD Million )
  8. North America Extracorporeal Cardiopulmonary Resuscitation (ECPR)) Market By Region, From 2016-2021 ( USD Million )
  9. United States Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  10. United States Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
  11. Canada Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2016-2021 ( USD Million )
  12. Canada Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2016-2021 ( USD Million )
Middle East And Africa Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Industry Analysis, Size, Share, Growth, Trends, And ...
Latin America Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts ...
Asia Pacific Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts (...
Europe Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016 ...
North America Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Industry Analysis, Size, Share, Growth, Trends And Forecasts ...
Walking Assist Devices Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters) And Region - Global Industry Analysis, Size, Share, Growth, Trends And Forecasts (2016 To...
Middle East And Africa Active Implantable Medical Devices Market By Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Impla...
Latin America Active Implantable Medical Devices Market By Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable He...
Middle East And Africa Hyperbaric Oxygen (HBO) Therapy Devices Market By Application (Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism, Others), By Product (Monoplace HBOT Devices, Multiplace...
Asia Pacific Active Implantable Medical Devices Market By Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hea...
Europe Active Implantable Medical Devices Market By Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing D...
Latin America Hyperbaric Oxygen (HBO) Therapy Devices Market By Application (Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism, Others), By Product (Monoplace HBOT Devices, Multiplace HBOT Dev...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.